The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2016

Filed:

Apr. 06, 2015
Applicant:

Allergan, Inc., Irvine, CA (US);

Inventors:

Patrick M. Hughes, Aliso Viejo, CA (US);

Michele Boix, Cantaron, FR;

Christian Sarrazin, Pegomas, FR;

Marina Do, Menton, FR;

Assignee:

Allergan, Inc., Irvine, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
B01J 13/02 (2006.01); A61K 9/50 (2006.01); A61K 9/16 (2006.01); A61K 9/107 (2006.01); A61K 9/00 (2006.01); A61K 47/34 (2006.01); B01J 13/04 (2006.01); B01J 13/06 (2006.01); A61K 31/165 (2006.01); A61K 31/216 (2006.01); A61K 31/5575 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5089 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 9/1075 (2013.01); A61K 9/1647 (2013.01); A61K 9/1694 (2013.01); A61K 9/5031 (2013.01); A61K 31/165 (2013.01); A61K 31/216 (2013.01); A61K 31/5575 (2013.01); A61K 47/34 (2013.01); B01J 13/02 (2013.01); B01J 13/04 (2013.01); B01J 13/06 (2013.01);
Abstract

Biocompatible intraocular implants, such as microparticles, include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the prostamide component may be encapsulated by the polymeric component. The present implants include oil-in-oil emulsified implants or microparticles. Methods of producing the present implants are also described. The implants may be placed in an eye to treat or reduce a at least one symptom of an ocular condition, such as glaucoma.


Find Patent Forward Citations

Loading…